Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 425 - 432 of 12093 results

EnforceMintz — Medicare Advantage and Part D Programs to Remain in the Enforcement Spotlight in 2025
January 16, 2025| Blog| Viewpoint

EnforceMintz —Could the Supreme Court’s Decision in Jarkesy Mean the End to HHS Civil Monetary Penalty Authorities as We Know Them?
January 16, 2025| Blog| Viewpoint

EnforceMintz — Healing Healthcare? DOJ’s Cybersecurity Enforcement Trained Up for 2025
January 16, 2025| Blog| Viewpoint

Health Law Diagnosed – The 2024 Election and Health Care Policy
January 16, 2025| Podcast| Viewpoint

Deadline Approaching for Massachusetts Pay Data Reporting
January 15, 2025| Blog| Viewpoint

Clouds Gather over ESG Investing as US Banks and Asset Managers Desert Climate Coalitions
January 15, 2025| News

Amazon Sr. Counsel Moves to Mintz's Tech, Telecom Practice
January 15, 2025| News

FTC Announces 2025 Thresholds for HSR Act Filings and Interlocking Directorates Violations
January 14, 2025| Alert| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
